✦ LIBER ✦

336 Splicing factors as novel therapeutic targets in ovarian and breast cancers

✍ Scribed by W. Beck; X. He; A.D. Arslan; T.T. Ho; N. Mahmud; M.D. Pool; J.S. Coon

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The epidermal growth factor receptor as

✍ Ting Gui; Keng Shen 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 281 KB

Nerve growth factor/nuclear factor-κB pa

✍ Ali Naderi; Luke Hughes-Davies 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 516 KB

PEA3 and HER-2/NEU — novel therapeutic t

✍ E. Myers; A. D. K. Hill; Y. Buggy; E. W. McDermott; N. J. O’Higgins; L. S. Young 📂 Article 📅 2002 🏛 Springer-Verlag 🌐 English ⚖ 218 KB

Gene therapy through signal transduction

✍ Adrian L. Harris; Steve Fox; Roy Bicknell; Russell Leek; Michele Relf; Sue Lejeu 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 518 KB

Estradiol receptors in breast cancer cel

✍ Jack-Michel Renoir 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 792 KB

Eag and HERG potassium channels as novel

✍ Viren Asher; Heidi Sowter; Robert Shaw; Anish Bali; Raheela Khan 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 524 KB